NSE ScannerHospitals & Diagnostics · Medical/Nursing Services · NSE: GAUDIUMIVF · data 2026-10-31
Gaudium IVF & Women Health Ltd.
In plain words
Price: 35.1% below its 52-week high of ₹163.18.
Delivery: 47.8% of traded shares were kept for delivery over the last 10 sessions, against 47.6% over the last 59.
Latest results: a net profit of ₹2 cr for the quarter ended Jun 2026.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | 33.1% |
| Profit growth, 3 years (yearly) | 21.8% |
At a glance
Promoters 71.3%, pledged 0.0%, institutions 3.4%.
ROE 24.7%, ROCE 35.0%: how much profit it earns on the money it uses.
Debt/equity 0.16, Profit growth 21.8% and sales growth 33.1% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- High return on equity (24.7%).
- Profit grew 21.8% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
GAUDIUMIVF Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹19.38 crore, down 36.1% QoQ.
Net profit was ₹1.78 crore, down 78.7% QoQ.
Operating margin was 12.5%.
EPS was ₹0.25, down 81.3% QoQ.
GAUDIUMIVF के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹19.38 करोड़; पिछली तिमाही की तुलना में 36.1% की गिरावट।
शुद्ध मुनाफ़ा: ₹1.78 करोड़; पिछली तिमाही की तुलना में 78.7% की गिरावट।
ऑपरेटिंग मार्जिन: 12.5%।
EPS: ₹0.25; पिछली तिमाही की तुलना में 81.3% की गिरावट।
GAUDIUMIVFના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹19.38 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 36.1% ઘટાડો.
ચોખ્ખો નફો: ₹1.78 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 78.7% ઘટાડો.
ઓપરેટિંગ માર્જિન: 12.5%.
EPS: ₹0.25; ગયા ક્વાર્ટરની સરખામણીએ 81.3% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Too few delivery days to compare delivery % (0 of 10); shares delivered not comparable (0 of 12); 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results
- 13 Aug 26Results Q1 FY27 results: net profit ₹1.8 cr 0.0% next session
- 29 May 26Results Q4 FY26 results: net profit ₹8.4 cr -1.8% next session
- 18 Mar 26Results Q3 FY26 results: net profit ₹3.6 cr -5.2% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹19 cr | ₹2 cr | — | 12.5% | 0.25 |
| Mar 2026 | ₹30 cr | ₹8 cr | — | 40.1% | 1.34 |
| Dec 2025 | ₹25 cr | ₹4 cr | — | 26.7% | 0.59 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Promoters | 71.29% | 71.29% | 71.29% |
| Foreign institutions (FII) | 1.19% | 3.02% | 6.70% |
| Domestic institutions (DII) | 2.22% | 2.22% | 2.62% |
| Mutual funds | 0.00% | — | — |
| Retail investors | 11.58% | 9.81% | 7.97% |
| Number of shareholders | 24,051 | 21,910 | 19,854 |
Common questions
What was Gaudium IVF & Women Health Ltd.'s latest quarterly profit?
Gaudium IVF & Women Health Ltd. reported a net profit of ₹2 cr for the quarter ended Jun 2026, on revenue of ₹19 cr.
How much do promoters hold in Gaudium IVF & Women Health Ltd.?
Promoters held 71.29% of Gaudium IVF & Women Health Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Gaudium IVF & Women Health Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.16.
What is the 52-week high and low of Gaudium IVF & Women Health Ltd.?
The 52-week high is ₹163.18 and the 52-week low is ₹69.18.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Gaudium IVF & Women Health Ltd. | ₹105.86 | ₹770 cr | — | — | 24.7% | 35% | 0.16 | +27.5% |
| Laxmi Dental Ltd. | ₹177.58 | ₹978 cr | 31.6 | — | 12.8% | 11.4% | 0.05 | -43.3% |
| Unihealth Hospitals Ltd | ₹550.25 | ₹875 cr | 33.1 | 6.3 | 21.4% | 22.7% | 0.24 | +221.8% |
| Max India Ltd | ₹147.22 | ₹828 cr | — | — | -31.8% | -26.9% | 0.24 | -30.6% |
| CHANDAN HEALTHCARE LIMITED | ₹235 | ₹575 cr | — | — | 18.4% | 23.4% | 0.31 | -33.8% |
| Rays of Belief Limited | ₹245.16 | ₹513 cr | — | — | — | — | — | +2.6% |
Compare GAUDIUMIVF with LAXMIDENTL in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open GAUDIUMIVF in NSE Scanner →